Article Information
History
- December 27, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Arianna Landini1,2,
- Paul R.H.J. Timmers1,2,
- Azra Frkatović-Hodžić3,
- Irena Trbojević-Akmačić3,
- Frano Vučković3,
- Tea Pribić,
- Regeneron Genetics Center4,
- Gannie Tzoneva4,
- Alan R. Shuldiner4,
- Ozren Polašek5,6,
- Caroline Hayward1,
- Gordan Lauc3,7,
- James F. Wilson*,1,2,† and
- Lucija Klarić*,1,†
- 1MRC Human Genetics Unit, Institute for Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom
- 2Centre for Global Health Research, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom
- 3Genos Glycoscience Research Laboratory, Zagreb, Croatia
- 4Regeneron Genetics Center, Tarrytown, NY, USA
- 5Department of Public Health, School of Medicine, University of Split, Split, Croatia
- 6Algebra University College, Zagreb, Croatia
- 7Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia
- ↵†Correspondence to: J.F.W (jim.wilson{at}ed.ac.uk) or L.K. (lucija.klaric{at}ed.ac.uk)
↵* Authors contributed equally.
Posted December 27, 2022.
Exome sequencing reveals aggregates of rare variants in glycosyltransferase and other genes influencing immunoglobulin G and transferrin glycosylation
